PMID- 12955669
OWN - NLM
STAT- MEDLINE
DCOM- 20031021
LR  - 20041117
IS  - 1537-6591 (Electronic)
IS  - 1058-4838 (Linking)
VI  - 37
IP  - 6
DP  - 2003 Sep 15
TI  - The role for intravenous immunoglobulin in the treatment of West Nile virus 
      encephalitis.
PG  - e88-90
AB  - Intravenous immunoglobulin (IVIG) with high titers to West Nile virus was used as 
      an adjuvant therapy for a patient with West Nile virus encephalitis that did not 
      respond to supportive care. We present this case report and review the evidence 
      supporting the use of high-titer IVIG.
FAU - Haley, Michael
AU  - Haley M
AD  - Department of Critical Care Medicine, Warren Magnuson Clinical Center, National 
      Institutes of Health, Bethesda, Maryland 20892, USA.
FAU - Retter, Avi S
AU  - Retter AS
FAU - Fowler, Daniel
AU  - Fowler D
FAU - Gea-Banacloche, Jaun
AU  - Gea-Banacloche J
FAU - O'Grady, Naomi P
AU  - O'Grady NP
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20030827
PL  - United States
TA  - Clin Infect Dis
JT  - Clinical infectious diseases : an official publication of the Infectious Diseases 
      Society of America
JID - 9203213
RN  - 0 (Immunoglobulins, Intravenous)
SB  - IM
MH  - Encephalitis/immunology/*therapy/virology
MH  - Humans
MH  - Immunoglobulins, Intravenous/*therapeutic use
MH  - Male
MH  - Middle Aged
MH  - West Nile Fever/immunology/*therapy
MH  - West Nile virus/*immunology
EDAT- 2003/09/05 05:00
MHDA- 2003/10/22 05:00
CRDT- 2003/09/05 05:00
PHST- 2003/02/14 00:00 [received]
PHST- 2003/05/14 00:00 [accepted]
PHST- 2003/09/05 05:00 [pubmed]
PHST- 2003/10/22 05:00 [medline]
PHST- 2003/09/05 05:00 [entrez]
AID - CID30962 [pii]
AID - 10.1086/377172 [doi]
PST - ppublish
SO  - Clin Infect Dis. 2003 Sep 15;37(6):e88-90. doi: 10.1086/377172. Epub 2003 Aug 27.